Our Company
RNACOREX is dedicated to llama biology and RNA engineering in service of biomedical research.
Making the llama immune repertoire accessible to research.
RNACOREX develops next-generation medical technologies at the intersection of animal immunization, VHH nanobodies and RNA production. Our conviction: the quality and traceability of starting biological material directly determine the success of the downstream nanobody discovery programs built on it.
The company runs its own R&D, as well as service and technology-transfer activities in the pharmaceutical and biotechnology fields, for academic and industrial partners.
Three non-negotiable standards.
Animal welfare
Every immunization protocol is designed and monitored in line with the 3Rs principle and EU Directive 2010/63, with ethics committee review and continuous veterinary oversight.
Scientific rigor
Every RNA batch is qualified using standardized methods (Qubit, TapeStation) before release, with full traceability from sample collection to delivery.
Transparency
Our methods, quality thresholds and protocols are documented and shared with our partners, with no ambiguity about the origin of the material supplied.
RNACOREX's key milestones.
R&D built out
Immunization, RNA extraction and quality control protocols are established, in compliance with EU Directive 2010/63.
Naive RNA launch
Qualified naive llama RNA stocks become available immediately for research and development teams.
Farm animals monitored with animal welfare as a priority.
